Selenium level does not differ in blood but increased in cerebrospinal fluid in Parkinson’s disease: a meta-analysis

References

• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
   PubMed Web of Science ®Google Scholar
• Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124(8):901–905.
   PubMed Web of Science ®Google Scholar
• Chen S, Zheng JC. Translational Neurodegeneration, a platform to share knowledge and experience in translational study of neurodegenerative diseases. Transl Neurodegener. 2012;1(1):1.
   PubMedGoogle Scholar
• Puspita L, Chung SY, Shim JW. Oxidative stress and cellular pathologies in Parkinson’s disease. Mol Brain. 2017;10(1):53.
   PubMed Web of Science ®Google Scholar
• Verma AK, Keshari AK, Raj J, et al. Prolidase-associated trace elements (Mn, Zn, Co, and Ni) in the patients with Parkinson’s disease. Biol Trace Elem Res. 2016;171(1):48–53.
   PubMed Web of Science ®Google Scholar
• Schomburg L. Dietary selenium and human health. Nutrients. 2016;9(1):22.
   Web of Science ®Google Scholar
• Hoffmann PR, Berry MJ. The influence of selenium on immune responses. Mol Nutr Food Res. 2008;52(11):1273–1280.
   PubMed Web of Science ®Google Scholar
• Siscar R, Koenig S, Torreblanca A, et al. The role of metallothionein and selenium in metal detoxification in the liver of deep-sea fish from the NW Mediterranean Sea. Sci Total Environ. 2014;466-467:898–905.
   PubMed Web of Science ®Google Scholar
• Vinceti M, Filippini T, Cilloni S, et al. The epidemiology of selenium and human cancer. Adv Cancer Res. 2017;136:1–48.
   PubMed Web of Science ®Google Scholar
• Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annu Rev Nutr. 2001;21(1):453–473.
   PubMedGoogle Scholar
• Bellinger FP, Raman AV, Rueli RH, et al. Changes in selenoprotein P in substantia nigra and putamen in Parkinson’s disease. J Parkinsons Dis. 2012;2(2):115–126.
   PubMedGoogle Scholar
• Cardoso BR, Roberts BR, Bush AI, et al. Selenium, selenoproteins and neurodegenerative diseases. Metallomics. 2015;7(8):1213–1228.
   PubMed Web of Science ®Google Scholar
• Maass F, Michalke B, Leha A, et al. Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson’s disease. J Neurochem. 2018;145(4):342–351.
   PubMed Web of Science ®Google Scholar
• Zhao HW, Lin J, Wang XB, et al. Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS One. 2013;8(12):e83060.
   PubMed Web of Science ®Google Scholar
• Qureshi GA, Qureshi AA, Memon SA, et al. Impact of selenium, iron, copper and zinc in on/off Parkinson’s patients on L-dopa therapy. J Neural Transm Suppl. 2006;71:229–236.
   Google Scholar
• Aguilar MV, Jimenez-Jimenez FJ, Molina JA, et al. Cerebrospinal fluid selenium and chromium levels in patients with Parkinson’s disease. J Neural Transm. 1998;105(10-12):1245–1251.
   PubMed Web of Science ®Google Scholar
• Hemmati-Dinarvand M, Taher-Aghdam AA, Mota A, et al. Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson’s disease. Clin Biochem. 2017;50(18):1087–1092.
   PubMed Web of Science ®Google Scholar
• Baillet A, Chanteperdrix V, Trocme C, et al. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson’s disease. Neurochem Res. 2010;35(10):1530–1537.
   PubMed Web of Science ®Google Scholar
• Gellein K, Syversen T, Steinnes E, et al. Trace elements in serum from patients with Parkinson’s disease–a prospective case-control study: the Nord-Trondelag Health Study (HUNT). Brain Res. 2008;1219:111–115.
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Santosh W. Metallomic profiling and linkage map analysis of early Parkinson’s disease: a new insight to aluminum marker for the possible diagnosis. PLoS One. 2010;5(6):e11252.
   PubMed Web of Science ®Google Scholar
• Nikam S, Nikam P, Ahaley SK, et al. Oxidative stress in Parkinson’s disease. Indian J Clin Biochem. 2009;24(1):98–101.
   PubMedGoogle Scholar
• Younes-Mhenni S, Aissi M, Mokni N, et al. Serum copper, zinc and selenium levels in Tunisian patients with Parkinson’s disease. Tunis Med. 2013;91(6):402–405.
   PubMedGoogle Scholar
• McIntosh KG, Cusack MJ, Vershinin A, et al. Evaluation of a prototype point-of-care instrument based on monochromatic x-ray fluorescence spectrometry: potential for monitoring trace element status of subjects with neurodegenerative disease. J Toxicol Environ Health A. 2012;75(21):1253–1268.
   PubMed Web of Science ®Google Scholar
• Jimenez-Jimenez FJ, Molina JA, Arrieta FJ, et al. Decreased serum selenium concentrations in patients with Parkinson’s disease. Eur J Neurol. 1995;2:111–114.
   PubMed Web of Science ®Google Scholar
• McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388–396.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Method. 2010;1(2):97–111.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97(6):1634–1658.
   PubMed Web of Science ®Google Scholar
• Prabhu KS, Lei XG. Selenium. Adv Nutr. 2016;7(2):415–417.
   PubMed Web of Science ®Google Scholar
• Power JH, Blumbergs PC. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117(1):63–73.
   PubMed Web of Science ®Google Scholar
• Blackinton J, Kumaran R, van der Brug MP, et al. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci Lett. 2009;452(1):8–11.
   PubMed Web of Science ®Google Scholar